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Rural Re-entry and Opioid Use: Identifying Health-Related Predictors of Relapse 
Among Formerly Incarcerated Women in Appalachia 
Abstract 
Introduction: Despite improved knowledge of the health care needs of formerly incarcerated women, there 
exists a gap regarding the relationship between health, health care access, and relapse among rural 
women returning to the community during the opioid epidemic. 
Purpose: With an emphasis on health care access, this study examined health-related factors associated 
with opioid relapse among women reentering the community in rural Appalachia. 
Methods: As part of a larger study, 400 rural women reporting a history of substance use were recruited 
from three Appalachian jails in Kentucky. Analyses focused on participants reporting a history of illicit 
opioid use prior to incarceration, who had also completed follow-up interviews at 6- and 12-months post-
release from jail. 
Results: Fifty-five percent of participants reported relapse to opioids during the 12-month follow-up 
period. Compared to those who did not use opioids during this time, women who relapsed reported 
poorer mental and physical health, as well as encountered more barriers to needed health services. They 
were also more likely to report a usual source of care. Multivariate regression analyses reveal that, even 
when controlling for other known correlates of opioid use and relapse to any non-opioid drug during the 
follow-up period, the number of barriers to health service utilization was a significant predictor of opioid 
relapse. 
Implications: Stakeholders should address the complex reentry needs of women who use opioids in rural 
Appalachia. This includes examining innovative approaches to reduce extensive barriers to quality health 
care utilization, such as implementing telehealth for opioid use treatment. 
Keywords 
Appalachia, opioid relapse, community re-entry, rural women, incarcerated women, substance abuse 
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omen have historically accounted for a minority proportion of the 
incarcerated population in the United States.1 Consequently, the bulk 
of scholarly attention to incarceration and re-entry experiences, 
including evidence-informed policy and program implications, has been 
androcentric.2 However, the incarceration rate for women increased at twice that 
of men during the prison boom (i.e., the period from 1973 to 2007 during which 
the incarceration rate rose dramatically from a historically stable rate of 161 per 
100,000 population to 767 per capita) and remains on the rise despite a recent 
downward trend in the overall rate.1 More recently, a growing movement towards 
decarceration has yielded commensurately high rates of community re-entry. 
Moreover, a larger percentage of these reintegrating citizens will be women than 
at any other timepoint, suggesting the importance of continued resources to 
support successful re-entry outcomes for women, who have diverse and complex 
re-entry needs.2,3 
 
One particular re-entry need among women that has been highlighted in the 
literature is health services. Existing studies suggest that women re-entering the 
community following incarceration have unique health needs,4 needs that may 
be intensified among those with a history of drug use.3 Opioid use, in particular, 
is associated with chronic physical or mental illness and disability.5 Women, 
however, often report encountering barriers to needed health services upon 
release from custody,6 despite evidence that access to health services can 
facilitate more successful re-entry outcomes.4 Notable barriers to health services 
reported by reintegrating citizens include insufficient means to pay for services, 
lapsed insurance coverage during incarceration, and limited health service 
options.7 
 
Women re-entering to rural communities may be further hindered by wide 
geographic dispersion of healthcare providers, limited transportation, and 
financial challenges due to widespread unemployment and economic 
marginalization.8 In Appalachian regions, these individuals also face elevated 
mortality rates associated with heart disease, cancer, stroke, diabetes, injury, 
suicide, and opioid overdose.9 The prevalence of health outcome disparities in 
rural Appalachian areas, combined with significant barriers to health services 
access and engagement, has resulted in an environment with high potential for 
opioid misuse and diversion.10 Widespread chronic pain, lack of economic and 
educational opportunity, and close-knit, place-based social networks all 
contribute to risks of substance use and untreated health concerns.11 For 
recently incarcerated rural women, this constellation of issues may be 
W 
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particularly salient as they navigate the complex process of recovery and re-
entry,3,12 which is associated with a heightened risk of drug overdose and death 
by other means (e.g., cardiovascular disease, homicide, and suicide).13 
 
Although untreated health problems are highly correlated with relapse and 
further criminal justice involvement for individuals re-entering the community,3 
little is known about the relationship between health, healthcare access, and 
relapse among rural women returning to the community within the context of 
the opioid epidemic, particularly in rural Appalachia. Therefore, the current 
study examines health-related predictors of opioid relapse among rural 
Appalachian women re-entering the community, while also considering the role 




As part of a larger study (NIH/NIDA 1R01-DA033866), 400 rural women with a 
history of drug use were recruited from three rural Appalachian jails in 
Kentucky. As described in greater depth elsewhere,14 participants were randomly 
selected, screened, and interviewed face-to-face at baseline between December 
2012 and August 2015. The final analytic sample for the current study was 
comprised of participants reporting a lifetime history of illicit opioid use prior to 
incarceration and who also completed follow-up interviews at both 6- and 12-
months post-release from jail (N=342). At follow-up, participants were asked 
about their mental and physical health, barriers to health services, and service 
utilization during community re-entry. 
 
MEASURES 
Demographics. Sociodemographic measures for this study included age (in 
years at baseline), education (years of formal education), and employment status 
(employed at least part-time during the follow-up period). 
 
Substance use. Substance use patterns were assessed via a dichotomous 
indicator of lifetime history of injection drug use, while opioid use severity was 
measured with the NIDA-Modified Alcohol, Smoking, and Substance Involvement 
Screening Test (NM-ASSIST). Specifically, participants answered items related to 
intensity and frequency of use for both street and prescription opioids, as well 
as a desire to use, life problems attributed to use, and how they and others felt 
about their use. Risk scores ranged from 0 to 39. An NM-ASSIST score of 4+ for 
any drug was a criterion for inclusion in the larger study. 
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Mental health. Mental health was measured using the Global Appraisal of 
Individual Needs (GAIN). Participants reporting symptoms consistent with each 
mental health problem (depression, anxiety, and post-traumatic stress disorder 
(PTSD)) were coded dichotomously (yes/no). Utilization of mental health 
treatment at any time during the 12-month follow-up period was also assessed 
via dichotomous self-report indicator. 
 
Physical health. To assess physical health, participants were asked if they 
experienced “a lot of physical pain or discomfort” during the follow-up period 
(yes/no). Additionally, the Miami Health Services Utilization questionnaire was 
administered to assess health problems and health service utilization. 
Participants were asked if they had a usual source and if they were currently 
being treated for a health problem (yes/no). Additional measures included 
barriers to health service utilization that were dichotomously coded, including: 
(1) could not afford medical care; (2) no insurance coverage; (3) did not have a 
way to get there; (4) too far to travel for care; (5) could not get appointment; and 
(6) right kind of service not available. Finally, the total number of barriers 
experienced was calculated. 
 
Outcome variable. The dependent variable (relapse to opioids) was a 
dichotomous indicator of self-reported opioid use at any point during the 12-
month follow-up study period. 
 
ANALYTIC PLAN 
Analyses conducted in 2019 first separated participants into two groups based 
on self-reported opioid use during the 12-month follow-up period: those who 
reported relapse to opioids (n=187) and those who did not (n=155). Then, a series 
of chi-square tests and t-tests were used to examine differences in demographics, 
mental and physical health, service utilization, and barriers to health services 
during community re-entry across the two groups. Finally, multivariate logistic 
regression models were used to examine health- and service-related predictors 
of opioid relapse during the follow-up period, while controlling for demographic 
differences and substance use, including non-opioid relapse. Statistical analyses 
employed two-tailed tests with an alpha level of 0.05 and were performed using 
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Overall, participants had an average age of 32.4 years old (SD=7.9), and half 
(50.6%) had not graduated high school at the time of baseline. The majority were 
white (98.8%), single (60.2%), and unemployed (72.2%). More than three-
quarters (77.2%) reported a history of injection drug use, while the mean opioid 
NM-ASSIST score was 28.8 (SD=13.2). Fifty-five percent (n=187) of participants 
self-reported using opioids during the 12-month follow-up period.  
 
BIVARIATE ANALYSES 
Compared to those who did not use opioids during the follow-up period (n=155), 
participants who relapsed were significantly younger (t(300.03)=2.43, p=0.016), 
less educated (t(340)=2.62, p=0.009), and less likely to be employed (χ2(1, 
N=342)=21.11, p<0.001). Those who relapsed to opioid use during the follow-up 
period also reported poorer mental and physical health than those who did not 
report any opioid use (Table 1). Specifically, they were significantly more likely 
to endorse criteria for depression (χ2(1, N=342)=11.34, p=0.001), anxiety (χ2(1, 
N=342)=19.07, p<0.001), and PTSD (χ2(1, N=342)=10.70, p=0.001). Those who 
used opioids during the follow-up period also were more likely to report 
experiencing physical pain and discomfort (χ2(1, N=342)=11.62, p=0.001) during 
the follow-up period. Individuals who relapsed during the follow-up period 
reported a higher mean opioid NM-ASSIST score (t(307.20)=-3.94, p<0.001) and 
were more likely to report a history of injection drug use (χ2(1, N=342)=23.31, 
p<0.001). 
 
Access to care also differed between groups. Individuals who relapsed to opioid 
use during the follow-up period encountered significantly more barriers to 
needed health services (t(340)=–2.80, p=0.005) compared to those who did not 
return to opioid use, including not having transportation (χ2(1, N=342)=6.04, 
p=0.014), long travel distances (χ2(1, N=342)=6.37, p=0.012), and being unable 
to get an appointment (χ2(1, N=342)=8.57, p=0.003). However, those who 
returned to opioid use were more likely to report a usual source of care when 
sick or for health consultation (χ2(1, N=342)=5.19, p=0.023).  
 
MULTIPLE REGRESSION ANALYSES 
Two logistic regression models were used to identify predictors of opioid relapse 
(Table 2). The first model focused on health-related predictors, revealing that 
experiencing pain more than doubled the odds of returning to opioid use during 
the follow-up (p=0.009) when controlling for demographic differences and 
substance use. Having a history of injection drug use (p<0.001), opioid use 
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severity (NM-ASSIST; p=0.040), and relapsing to any other non-opioid drug 
(p<0.001) also increased the likelihood of opioid relapse. On the other hand, 
being older (p=0.008), more educated (p=0.017), and employed (p=0.005) 
decreased the likelihood of opioid relapse. The second logistic regression model 
incorporated service barriers and having a source of care. Results showed that 
experiencing pain was no longer a significant predictor of opioid relapse when 
including access to care in the model and controlling for demographic differences 
and substance use. For each additional barrier to care reported, the likelihood 
of relapsing to opioid use increased by 22% (p=0.043), though having a usual 
source of care also increased the odds of relapsing (AOR=1.77; p=0.046). 
 
Table 1. Health, Healthcare Utilization, and Barriers to Care by Opioid 
Relapse During 12-month Follow-up (N=342) 







Mental Health – GAIN   
% Major Depressive Disorder*** 58.3% 40.0% 
% Generalized Anxiety Disorder*** 33.2% 12.9% 
% Post-traumatic Stress Disorder*** 61.0% 43.2% 
% received MH treatment in the past 12 
months 
28.3% 29.0% 
Physical Health   
% had a lot of physical pain/discomfort*** 57.2% 38.7% 
% currently being treated for a health 
problem 
40.1% 41.9% 
% had a usual source of care* 62.6% 50.3% 
Substance Use   
Mean opioid NM-ASSIST score (SD)*** 31.3 (12.1) 25.7 (13.9) 
% ever injected any drug in lifetime*** 87.2% 65.2% 
Barriers to Care   
Could not afford medical care 29.4% 24.5% 
No insurance coverage 29.9% 25.8% 
No way to get there/transportation* 39.0% 26.5% 
Too far to travel for care* 20.3% 10.3% 
Could not get an appointment** 13.9% 4.5% 
Right kind of service not available 10.7% 6.5% 
Total # of barriers experienced** 1.4 1.0 
* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001; GAIN Global Appraisal of Individual Needs, NM-
ASSIST NIDA-Modified Alcohol, Smoking, and Substance Involvement Screening Test 
28
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Table 2. Correlates of Opioid Relapse during 12-month Follow-up (N=342) 
 Model #1 Model #2 
Variable Adj. Odds Ratio 
 (CI 95) 
Adj. Odds Ratio 
(CI 95) 


































# of barriers to health care — 1.22*  
(1.01–1.49) 
Usual source of health care — 1.77*  
(1.01–3.11) 
Note: Significant associations are bolded. 
* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001; NM-ASSIST NIDA-Modified Alcohol, Smoking, 





With a focus on healthcare access, this study investigated factors associated with 
opioid relapse during community re-entry in rural Appalachia among a sample 
of women. Results indicate that women who relapsed to opioid use self-reported 
having more mental and physical health problems, as well as having a usual 
source of care. However, these participants experienced greater difficulty in 
accessing needed health services. Overall, these findings suggest that women 
who relapsed to opioids may be self-medicating to manage pain, but access to 
care may impact self-medication. This may signal important implications, 
including examining approaches to improving access to quality health care in 
rural Appalachia, particularly for opioid-using women re-entering the 
community after jail.  
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Barriers to care were often related to travel and resource availability, like 
physical distance, inadequate transportation, and limited appointment 
availability. This finding reaffirms prior research on substance use and 
healthcare utilization, which identifies scarce access as a principal factor 
associated with low utilization rates.15 Overall, the supply of specialty physicians 
in Appalachia is about 28% lower than the national average.9 Central Appalachia 
(inclusive of Eastern Kentucky) stands out among an already disadvantaged 
region in this metric, having only 54 specialists per 100,000 population (i.e., fully 
65% lower than the national average). Further, Central Appalachia also has 
approximately 33% fewer primary care physicians per capita than the rest of the 
nation.9 
 
Telehealth is a promising service modality that may alleviate availability and 
access barriers for this population of women who use substances.16 Broadly, 
telehealth may refer to “(1) telemedicine or synchronous videoconferencing 
between clinicians and patients in separate locations; and (2) mobile health, 
involving telephone, text, or web-based interventions.”16 This service modality 
allows patients to access a large pool of physicians and clinicians across 
potentially great geographic distances, easing access issues for women re-
entering the community. While Central Appalachia is characterized as having a 
dearth of primary care physicians, it is encouraging that, with 137 mental health 
providers per capita, the subregion has a larger proportion than Appalachia at 
large.9 In this case, telehealth could be used as a tool by the existing primary 
care and mental healthcare infrastructure in Appalachia to enhance access to 
specialized treatment for reintegrating women.9,15 This is an important 
consideration for future scientific inquiry because implementing telehealth for 
those who use substances in rural areas is not without its challenges, such as 
legislative and regulatory impediments (e.g., reimbursement and prescription 
restrictions), technological and infrastructure-related limitations, and clinician 
reticence.16 
 
Scholars suggest initiating telehealth in correctional facilities prior to release, 
particularly for those with a history of substance use.17 Though the 
implementation of telehealth in correctional settings currently varies widely, it is 
generally associated with patient satisfaction, positive clinical outcomes, and 
reduced costs over time.17 However, there are also a variety of perceived barriers 
associated with telehealth delivered in this context, such as initial cost of 
equipment and maintenance, as well as resistance from staff.18 Future research 
should explore the utility of initiating telehealth while incarcerated and 
continuing it upon release for this population.  
30
Calvert et al.: Health-Related Predictors of Opioid Relapse During Rural Re-entry
Published by the University of Kentucky, 2021
 
 
It is also important to note that barriers to care experienced by those re-entering 
the community from jail may be exacerbated by the current COVID-19 crisis. 
Studies have linked pandemic-related social restrictions to a variety of negative 
outcomes, such as increased financial strain, elevated rates of perceived stress 
and depression symptoms, and decreased healthcare utilization among 
Appalachian samples.19 With their unique re-entry needs, women may be 
especially negatively impacted in this regard. For example, Staton and colleagues 
report elevated perceptions of social isolation among their sample of Appalachian 
women during the pandemic.20 Considering this, coupled with mounting 
pressure for large-scale decarceration in response to the COVID-19 pandemic,21 
it is particularly timely and essential that health and criminal justice resources 
focus on supporting women as they are released from jail into rural areas. Future 
research should specifically examine the ways in which re-entry processes and 
experiences may evolve for women in rural areas in a post-COVID social 
environment. 
 
Another noteworthy finding is that relapse to opioids was positively associated 
with having a usual source of care. While unanticipated and perhaps 
confounding upon initial reflection, this may indicate that a lack of accessible 
healthcare providers is only one piece of a complex puzzle. One potential 
explanation for this finding is that these women may have chronic and/or severe 
health issues, for which they self-medicate to supplement their usual source of 
care. For example, while some women re-entering the community from jail have 
a usual source of care, they may experience barriers to adequately utilizing this 
resource, thus they rely on self-medication. Another explanation may be that 
stigma and suspicion among rural healthcare providers regarding people who 
use substances, particularly those who use opioids, affects the quality of 
physician–patient interaction and the level of care provided, including a 
reluctance to prescribe medication that could potentially be diverted (e.g., 
buprenorphine).22 Despite a paradigm shift towards treating substance use 
disorder and addiction as a disease, those who use substances continue to face 
social stigma in the form of stereotyping (e.g., perceptions of dangerousness, 
immorality, unpredictability, and culpability); general negative emotional 
reactions (e.g., fear and anger); and discrimination (e.g., social isolation and 
decreased intention to help).23 For the current sample, recent involvement with 
the criminal justice system may intensify this stigma, creating an additional 
barrier to care worthy of scholarly attention. Though study analyses do not 
necessarily indicate a causal relationship between having a usual source of care 
and relapse to opioids, future research should consider a more in-depth 
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examination of this association, including the possible influence of mediating 
variables.  
 
These explanations further highlight the importance of reducing barriers to 
accessing care, as well as point towards the potential of telehealth as a bridge to 
care for women who use opioids. This is especially salient given the following 
considerations: (1) drug-related overdose mortality rates have increased steadily 
over the past couple decades, with opioids and synthetic opioids accounting for 
a growing share in recent years (e.g., more than two-thirds of overdose deaths in 
2017)24; (2) the first 2 to 4 weeks immediately following release from custody 
present a critical period of heightened risk of death for former inmates, with 
overdose being the leading cause of death (i.e., 129 times more likely than the 
general population)13; and (3) injection drug/opioid use is associated with the 
spread of bloodborne illnesses, like hepatitis C.25 
 
The present findings should be interpreted in light of several limitations. This 
study relied on a self-reported indicator of opioid relapse, which is a potentially 
sensitive and illegal behavior. Additionally, while interviews were completed in a 
private setting within the jails or community, some participants may have been 
concerned about the confidentiality of their responses. Therefore, the risk of 
social desirability influencing responses cannot be ruled out, which poses a 
threat to validity and reliability. As such, caution should be exercised when 
considering causality and prediction in the observed relationships between study 
variables. Participants were recruited from three rural Appalachian jails, which 
may limit the generalizability of results to those reintegrating from prisons or 
those re-entering into rural, non-Appalachian communities. Finally, current 
analyses did not incorporate a measure of relationship trauma or partner 
violence for the women in this sample, despite existing evidence of an association 
between trauma and substance use.3 Future studies should consider this 
potential connection as it could also impact women’s healthcare needs. 
 
Despite these limitations, the current study enhances scholarly understanding 
of the factors that impact opioid relapse among formerly incarcerated women re-
entering the community from jail in rural Appalachia. In response to the results 
of this study, policymakers and healthcare professionals should: (1) focus 
discharge/re-entry resources to support the unique needs of women re-entering 
rural communities, particularly as the social landscape changes while the 
COVID-19 pandemic continues to evolve (e.g., SARS-CoV-2 Delta); and (2) 
examine innovative ways to improve health status and erode barriers to 
healthcare utilization among this population. This includes exploring the 
feasibility of permanently lifting applicable legislative, regulatory, and 
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reimbursement restrictions, as well as addressing other social and technical 
challenges (e.g., telecommunications infrastructure), that impede the 
implementation of telehealth services in the Appalachian region.  
 
SUMMARY BOX 
What is already known on this topic? Existing studies suggest that justice-
involved women with a history of drug use have greater healthcare needs, and 
despite evidence indicating that having access to health services during re-entry 
can facilitate more successful outcomes, many report encountering barriers to 
needed health services upon release from custody.  
What is added by this report? There is a limited understanding of the 
relationship between health, healthcare access, and relapse among justice-
involved rural Appalachian women returning to the community after a period of 
incarceration, particularly within the context of the opioid epidemic. This report 
provides evidence of the amplified mental and physical healthcare needs of 
women who relapse to opioid use during community re-entry and the difficulty 
they experience in accessing needed health services. 
What are the implications for future research? Results highlight the 
importance of supporting the health needs of rural Appalachian women with a 
history of opioid use who are re-entering the community following incarceration, 
as well as addressing the far-reaching barriers to healthcare utilization they face. 
Further research is needed on improving access to quality health care for women 
who use opioids, which may include utilizing telehealth as a bridge to care and 
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